Chemotherapeutic agents such as cisplatin and paclitaxel, involved in platinum-based chemotherapy, and gefitinib, one of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs), are first-line treatments for NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.